Related Experiment Videos
Accelerated atherosclerosis
S S Samra1, P P Walwaikar, V K Morye
1JB Chemicals and Pharmaceuticals Ltd, Mumbai 400025.
Journal of the Indian Medical Association
|April 5, 2003
Summary
Accelerated atherosclerosis involves endothelial injury, platelet activation, and smooth muscle cell proliferation, leading to vascular occlusion. Calcium channel blockers like nifedipine may offer vasoprotection against this condition.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Pharmacology
Background:
- Accelerated atherosclerosis shares mechanisms with spontaneous forms, including endothelial injury, platelet involvement, smooth muscle cell proliferation, and thrombosis.
- Unlike spontaneous atherosclerosis, accelerated forms are characterized by significant denuding endothelial injury as the critical initiating event.
- Risk factors such as cigarette smoking and hypertension significantly contribute to the progression of accelerated atherosclerosis.
Purpose of the Study:
- To review the role of nifedipine in managing accelerated atherosclerosis.
- To explore the potential of calcium antagonists in preventing vascular occlusion and restenosis.
- To understand the pathophysiologic mechanisms underlying accelerated atherosclerosis and identify therapeutic strategies.
Main Methods:
- Review of existing literature on accelerated atherosclerosis and calcium channel blockers.
- Analysis of pathophysiologic mechanisms including endothelial injury, platelet aggregation, smooth muscle cell proliferation, and vasospasm.
- Evaluation of the effects of calcium antagonists, specifically nifedipine, on these processes.
Main Results:
- Accelerated atherosclerosis leads to premature coronary occlusion in specific patient groups, causing significant morbidity and mortality.
- Calcium channel blockers demonstrate positive effects on restenosis-associated processes, including reduced platelet aggregation, minimized vasospasm, and inhibited mitogenesis.
- Nifedipine's role in providing vasoprotection and anti-arteriosclerotic effects in accelerated atherosclerosis is highlighted.
Conclusions:
- Accelerated atherosclerosis is a significant clinical problem, particularly in post-transplant patients, those with diabetes, and after interventions like angioplasty.
- Calcium channel blockers, such as nifedipine, represent a promising prophylactic strategy for anti-arteriosclerotic protection.
- Nifedipine may offer superior anti-arteriosclerotic benefits compared to other interventions by addressing multiple pathophysiologic pathways involved in accelerated atherosclerosis.